Kodiak Sciences Inc at JPMorgan NAPA Valley Forum (Virtual) Transcript

Mar 31, 2021 / 03:00PM GMT
Anupam Rama - JPMorgan Chase & Co, Research Division - VP and Analyst

Welcome, everyone, to the 10th Annual and 2021 JPMorgan Napa Valley Biotech Forum.

Our next presenting company here is Kodiak. And presenting on behalf of the company, we have CEO, Victor Perlroth. (Operator Instructions)

Victor, if you want to introduce the broader team on the line here, we can get started.

Victor Perlroth - Kodiak Sciences Inc. - Chairman, MD, CEO & President

Yes. Well, I'm Victor Perlroth, I'm the CEO of Kodiak. Thanks a lot, Anupam. We're glad to be part of the conference. And then we also have Jason Ehrlich, our Chief Medical and Development Officer on the line as well. So we'll look forward to chatting with you for the 45 minutes.

Questions and Answers:

Anupam Rama - JPMorgan Chase & Co, Research Division - VP and Analyst

Yes. So related to the KSI-301 ongoing Phase III studies, with DAZZLE enrollment and wet AMD complete, how are you thinking about the enrollment curves of GLEAM, GLIMMER
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot